Monopar Therapeutics(us:MNPR)
33.43
-8.18%
Updated on 2025-04-02
Open:34.96
Close:33.43
High:36.46
Low:31.79
Prev Close:36.41
Volume:37168.00
Turnover:1.23M
Turnover Ratio:0.61%
Shares:6.11M
MarketCap:204.34M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 17 | 83632 | 0.48% | 1 | 5 | 6 |
| 2024-03-31 | 19 | 395328 | 2.26% | 6 | 3 | 5 |
| 2023-12-31 | 17 | 271312 | 1.82% | 4 | 4 | 6 |
| 2023-09-30 | 14 | 301310 | 2.12% | 6 | 0 | 6 |
| 2023-06-30 | 13 | 192440 | 1.38% | 2 | 2 | 6 |
| 2023-03-31 | 12 | 220920 | 1.67% | 3 | 2 | 3 |
| 2022-12-31 | 11 | 188033 | 1.45% | 1 | 3 | 5 |
| 2022-09-30 | 14 | 199126 | 1.55% | 2 | 3 | 5 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Millennium Management Llc | 192381 | 1.10% | 163040 | 555.67% |
| 2024-03-31 | Vanguard Group Inc | 45167 | 0.26% | 0 | |
| 2024-03-31 | Geode Capital Management, Llc | 41199 | 0.24% | 0 | |
| 2024-03-31 | Hrt Financial Lp | 32113 | 0.18% | 32113 | |
| 2024-03-31 | Gerber, Llc | 28005 | 0.16% | 0 | |
| 2024-03-31 | Virtu Financial Llc | 23827 | 0.14% | -3343 | -12.30% |
| 2024-03-31 | Rappaport Reiches Capital Management, Llc | 10695 | 0.06% | 0 | |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 7856 | 0.04% | 4238 | 117.14% |
| 2024-03-31 | Fmr Llc | 5500 | 0.03% | 5500 | |
| 2024-03-31 | Newedge Advisors, Llc | 3000 | 0.02% | 3000 |
About
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Address:1000 Skokie Boulevard,Suite 350
Website:http://www.monopartx.com
Market Movers